Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 3
1947 4
1948 3
1949 1
1950 3
1951 11
1952 9
1953 6
1954 12
1955 7
1956 5
1957 14
1958 14
1959 17
1960 20
1961 19
1962 23
1963 46
1964 62
1965 70
1966 180
1967 215
1968 212
1969 198
1970 210
1971 186
1972 199
1973 231
1974 295
1975 369
1976 407
1977 604
1978 981
1979 1193
1980 15688
1981 33527
1982 34552
1983 35011
1984 36720
1985 37423
1986 38594
1987 39980
1988 41169
1989 42777
1990 44857
1991 46131
1992 46731
1993 47468
1994 48955
1995 49372
1996 49570
1997 49888
1998 50858
1999 52372
2000 54940
2001 56314
2002 59372
2003 63595
2004 71261
2005 77915
2006 86499
2007 93079
2008 103171
2009 109975
2010 119307
2011 128400
2012 132946
2013 138107
2014 139503
2015 140630
2016 135890
2017 130969
2018 133236
2019 134283
2020 146617
2021 153179
2022 138719
2023 133951
2024 48719
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

3,263,216 results

Results by year

Filters applied: . Clear all
Page 1
Defining the risk of SARS-CoV-2 variants on immune protection.
DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, Alter G, Amara RR, Baric RS, Barouch DH, Bloom JD, Bloyet LM, Bonenfant G, Boon ACM, Boritz EA, Bratt DL, Bricker TL, Brown L, Buchser WJ, Carreño JM, Cohen-Lavi L, Darling TL, Davis-Gardner ME, Dearlove BL, Di H, Dittmann M, Doria-Rose NA, Douek DC, Drosten C, Edara VV, Ellebedy A, Fabrizio TP, Ferrari G, Fischer WM, Florence WC, Fouchier RAM, Franks J, García-Sastre A, Godzik A, Gonzalez-Reiche AS, Gordon A, Haagmans BL, Halfmann PJ, Ho DD, Holbrook MR, Huang Y, James SL, Jaroszewski L, Jeevan T, Johnson RM, Jones TC, Joshi A, Kawaoka Y, Kercher L, Koopmans MPG, Korber B, Koren E, Koup RA, LeGresley EB, Lemieux JE, Liebeskind MJ, Liu Z, Livingston B, Logue JP, Luo Y, McDermott AB, McElrath MJ, Meliopoulos VA, Menachery VD, Montefiori DC, Mühlemann B, Munster VJ, Munt JE, Nair MS, Netzl A, Niewiadomska AM, O'Dell S, Pekosz A, Perlman S, Pontelli MC, Rockx B, Rolland M, Rothlauf PW, Sacharen S, Scheuermann RH, Schmidt SD, Schotsaert M, Schultz-Cherry S, Seder RA, Sedova M, Sette A, Shabman RS, Shen X, Shi PY, Shukla M, Simon V, Stumpf S, Sullivan NJ, Thackray LB, Theiler J, Thomas PG, Trifkovic S, Türeli S, Turn… See abstract for full author list ➔ DeGrace MM, et al. Nature. 2022 May;605(7911):640-652. doi: 10.1038/s41586-022-04690-5. Epub 2022 Mar 31. Nature. 2022. PMID: 35361968 Free PMC article. Review.
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immunity induced after infection or vaccination. To address the public health threat caused by the increasing SARS-CoV-2 genomic diversit …
The global emergence of many severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants jeopardizes the protective antiviral immu …
Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
Whitehead SS. Whitehead SS. Expert Rev Vaccines. 2016;15(4):509-17. doi: 10.1586/14760584.2016.1115727. Epub 2015 Dec 2. Expert Rev Vaccines. 2016. PMID: 26559731 Free PMC article. Review.
Although the multi-dose vaccine demonstrated protection against severe dengue, its overall efficacy was limited by DENV serotype, serostatus at vaccination, region and age. The National Institute of Allergy and Infectious Diseases …
Although the multi-dose vaccine demonstrated protection against severe dengue, its overall efficacy was limited by DENV serotype, serostatus …
Anaphylaxis in children.
Farbman KS, Michelson KA. Farbman KS, et al. Curr Opin Pediatr. 2016 Jun;28(3):294-7. doi: 10.1097/MOP.0000000000000340. Curr Opin Pediatr. 2016. PMID: 26963947 Free PMC article. Review.
Children with anaphylaxis who have resolving symptoms and no history of asthma or previous biphasic reactions may be observed for as few as 3-4 h before emergency department discharge. Early peanut introduction reduces the risk of peanut allergy. SUMMARY: Epinephrine remai …
Children with anaphylaxis who have resolving symptoms and no history of asthma or previous biphasic reactions may be observed for as few as …
Radiation-induced multi-organ injury.
Molinar-Inglis O, DiCarlo AL, Lapinskas PJ, Rios CI, Satyamitra MM, Silverman TA, Winters TA, Cassatt DR. Molinar-Inglis O, et al. Int J Radiat Biol. 2024;100(3):486-504. doi: 10.1080/09553002.2023.2295298. Epub 2024 Jan 2. Int J Radiat Biol. 2024. PMID: 38166195
METHODS: The Radiation and Nuclear Countermeasures Program within the National Institute of Allergy and Infectious Diseases partnered with the Biomedical Advanced Research and Development Authority to convene a virtual two-d …
METHODS: The Radiation and Nuclear Countermeasures Program within the National Institute of Allergy and …
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop.
Naclerio R, Baroody F, Bachert C, Bleier B, Borish L, Brittain E, Chupp G, Fisher A, Fokkens W, Gevaert P, Kennedy D, Kim J, Laidlaw TM, Lee JJ, Piccirillo JF, Pinto JM, Roland LT, Schleimer RP, Schlosser RJ, Schwaninger JM, Smith TL, Tan BK, Tan M, Toskala E, Wenzel S, Togias A. Naclerio R, et al. J Allergy Clin Immunol Pract. 2020 May;8(5):1532-1549.e1. doi: 10.1016/j.jaip.2020.02.023. Epub 2020 Mar 4. J Allergy Clin Immunol Pract. 2020. PMID: 32142964 Free PMC article. Review.
However, other therapies are also available, and positioning of biologics in a management algorithm will require comparative trials. In November 2019, the National Institute of Allergy and Infectious Diseases convened a workshop to …
However, other therapies are also available, and positioning of biologics in a management algorithm will require comparative trials. In Nove …
The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance.
Peters NK, Dixon DM, Holland SM, Fauci AS. Peters NK, et al. J Infect Dis. 2008 Apr 15;197(8):1087-93. doi: 10.1086/533451. J Infect Dis. 2008. PMID: 18419527 Review.
Antimicrobial resistance is an intrinsic and inevitable aspect of microbial survival that continually challenges human health. Research on antimicrobial resistance is central to the mission of the National Institute of Allergy and …
Antimicrobial resistance is an intrinsic and inevitable aspect of microbial survival that continually challenges human health. Res …
An evaluation of programs to support new investigators at the National Institute of Allergy and Infectious Diseases: Striking a balance with funding for established investigators.
Zane AC, Onken J, Parker MB, Ghosh D. Zane AC, et al. Eval Program Plann. 2023 Jun;98:102218. doi: 10.1016/j.evalprogplan.2022.102218. Epub 2022 Dec 21. Eval Program Plann. 2023. PMID: 36963190 Free PMC article.
As the largest funder of basic biomedical research in the US, the National Institutes of Health (NIH) has an interest in maintaining a sustainable, productive workforce of investigators. ...Each IC must balance support for new investigators with …
As the largest funder of basic biomedical research in the US, the National Institutes of Health (NIH) has …
Preface.
Gezmu M, Qin J. Gezmu M, et al. Stat Med. 2018 Jan 30;37(2):179-180. doi: 10.1002/sim.7551. Stat Med. 2018. PMID: 29250840 No abstract available.
Development of a Universal Influenza Vaccine.
Estrada LD, Schultz-Cherry S. Estrada LD, et al. J Immunol. 2019 Jan 15;202(2):392-398. doi: 10.4049/jimmunol.1801054. J Immunol. 2019. PMID: 30617121 Free PMC article. Review.
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our current seasonal influenza vaccine. Thus, the National Institute of Allergy and Infectious Dis …
The severity of the 2017-18 influenza season, combined with the low efficacy for some vaccine components, highlights the need to improve our …
3,263,216 results
You have reached the last available page of results. Please see the User Guide for more information.